FiercePharma |
Post-Endo pact, will Vivus go it alone on US Stendra marketing--and should it?
FiercePharma Back in January, Endo walked away from its U.S. marketing pact with Vivus over erectile dysfunction med Stendra. And with the termination date for their agreement approaching, Vivus still isn't sure what it's going to do to fill the gap. Come September ... |
August 05, 2016 at 01:24PM | marketing - Google News
Post-Endo pact, will Vivus go it alone on US Stendra marketing--and should it? - FiercePharma
marketing - Google News
Nenhum comentário:
Postar um comentário